Jennifer Fuehrer
Foot & Ankle Surgery · Norwalk, IANPI 1932462256
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (56.2%), food and beverage and other — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Wardlow Enterprises at 55.1% of the total. Reporting peaked in 2021 at $1,522 and has fallen 69.4% since, to $466 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in IA, where the typical reported total is $2,625.
Across 58 payments — averaging $56.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Wardlow Enterprises$2K
- Stryker$596
- Medline Industries LP$160
- Bioventus LLC$145
- Integra Lifesciences Corporation$113
- Smith+Nephew$105
- plus $347 from 10 others
What the payments were for
- Food & beverage$1,34141%
- Education$1,83356%
- Other$873%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Wardlow Enterprises | 2 | $1,796 |
| Stryker | 22 | $596 |
| Medline Industries LP | 2 | $160 |
| Bioventus LLC | 7 | $145 |
| Integra Lifesciences Corporation | 2 | $113 |
| Smith+Nephew | 6 | $105 |
| Amgen(2 entities) | 5 | $88 |
| Johnson & Johnson | 3 | $69 |
| Acera Surgical, Inc. | 1 | $54 |
| Orthofix Medical, Inc. | 2 | $26 |
| Kerecis Limited | 1 | $24 |
| Treace Medical Concepts, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $17 |
| Organogenesis Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
How this compares
$3,261 in reported general payments places this provider in the 50th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 31 | $615 |
| Methylprednisolone | 25 | $201 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $195 |
| Gabapentin | 20 | $159 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $77 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Norwalk
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
- Sean GrambartDes Moines$590K
- Kelsey MillonigDes Moines$330K
- Charles CibulaCedar Falls$38K
- Gregory FooteWaterloo$35K
- Nathan ShumwayCouncil Bluffs$33K
- Justin RaatzDes Moines$28K
- Tuvi MendelDavenport$26K
- Mica MurdochDes Moines$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.